Beijing, China; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Combination Therapy in Heart Transplant Patients.
Fuzhou, China; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Combination Therapy in Heart Transplant Patients.
Shanghai, China; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Combination Therapy in Heart Transplant Patients.
Heidelberg, Germany; Research Site:
Heart Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Rapamune (Sirolimus) in Heart Transplant Recipients
Jena, Germany; Research Site:
Heart Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Rapamune (Sirolimus) in Heart Transplant Recipients
Milano, Italy; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Heart Transplant Patients.
Napoli, Italy; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Heart Transplant Patients.
Pavia, Italy; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Heart Transplant Patients.
Udine, Italy; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Heart Transplant Patients.
Barcelona, Spain; Research Site:
A Study of CellCept (Mycophenolate Mofetil) and Zenapax in Prevention of Acute Rejection in Heart Transplant Patients
El Palmar Murcia, Spain; Research Site:
A Study of CellCept (Mycophenolate Mofetil) and Zenapax in Prevention of Acute Rejection in Heart Transplant Patients
La Coruna, Spain; Research Site:
A Study of CellCept (Mycophenolate Mofetil) and Zenapax in Prevention of Acute Rejection in Heart Transplant Patients
Madrid, Spain; Research Site:
A Study of CellCept (Mycophenolate Mofetil) and Zenapax in Prevention of Acute Rejection in Heart Transplant Patients
Oviedo, Spain; Research Site:
A Study of CellCept (Mycophenolate Mofetil) and Zenapax in Prevention of Acute Rejection in Heart Transplant Patients
Pamplona, Spain; Research Site:
A Study of CellCept (Mycophenolate Mofetil) and Zenapax in Prevention of Acute Rejection in Heart Transplant Patients
Santander, Spain; Research Site:
A Study of CellCept (Mycophenolate Mofetil) and Zenapax in Prevention of Acute Rejection in Heart Transplant Patients
Sevilla, Spain; Research Site:
A Study of CellCept (Mycophenolate Mofetil) and Zenapax in Prevention of Acute Rejection in Heart Transplant Patients
